Connecting Research and Experts with Journalists

• share
• favorite_border

Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma (cHL) is treated. Details appear in a study published today in The New England Journal of Medicine. Drs. Kara Kelly of Roswell Park Comprehensive Cancer Center and Sharon Castellino of Children’s Healthcare of Atlanta and Emory University School of Medicine/Winship Cancer Institute of Emory University served as pediatric leads of this important trial in children and adults with lymphoma.

• share
• favorite_border

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say the findings could shape treatment approaches to one of the most challenging symptoms experienced by people with multiple sclerosis.

• share
• favorite_border

According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV.

• share
• favorite_border

A study led by Adam Rodman, MD, MPH, Director of AI Programs at Beth Israel Deaconess Medical Center (BIDMC), reveals that, rather than helping to reduce racial and ethnic biases, AI-driven chatbots may instead perpetuate and exacerbate disparities in medicine.

• share
• favorite_border

Reporters are invited to this briefing about research from the Wilmot Cancer Institute at the University of Rochester Medical Center, with a new study to be published in the New England Journal of Medicine (NEJM).

• share
• favorite_border

UC San Diego School of Medicine researchers discover a groundbreaking oral breast cancer drug that is also effective in treating a rare form of appendix cancer.

• share
• favorite_border

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers found that the likelihood of good recovery was similar between the two treatments.

• share
• favorite_border

For people with stroke, social factors such as race, neighborhood and insurance, may be linked to whether they receive treatment, according to a study published in the October 16, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.